The short answer
The inspected research does not establish that Plectranthus barbatus changes clonidine absorption or effectiveness. Studies of related medicinal root preparations have mixed blood-pressure findings and did not test this combination. The exact botanical and extract should be checked before use.
What this answer covers
Oral Plectranthus barbatus root preparations with oral clonidine. Historical medicinal studies use Coleus/forskohlii naming; naming and extract identity require confirmation, and isolated forskolin is a separate exposure.
- Supplement or preparation
- Plectranthus barbatus
- Medication ingredient
- clonidine
What does the existing warning leave unclear?
A statement that the herb may change how clonidine works could mean a pressure effect, an absorption change or something else. The sources inspected do not demonstrate clonidine pharmacokinetics or clinical co-use outcomes. These mechanisms should not be treated as interchangeable.
What did the clinical studies find?
A placebo-controlled study in overweight or obese adults found no significant blood-pressure effect from its extract over 12 weeks. A smaller comparison of two root formulations reported pressure reductions from baseline, but had no inert placebo group. Neither tested the requested combination.
Why check the botanical name and formulation?
Medicinal sources connect forskohlii products with Plectranthus barbatus, but historical nomenclature is inconsistent. A name alone does not verify the species, root preparation or forskolin content in a bottle. The published extracts should not be generalized to an unidentified product.
Is there a protective schedule?
No clinically validated interval was established in the inspected research. Discuss the actual product and your blood-pressure treatment with a pharmacist, and keep clonidine on its prescribed schedule unless your prescriber advises a change.
Evidence and practical considerations
Absorption & effectiveness
No exact-pair clinical or absorption effect is established; preparation-specific blood-pressure findings are indirect and inconsistent.
- Exact scope
- Oral Plectranthus barbatus root preparations with oral clonidine. Historical medicinal studies use Coleus/forskohlii naming; naming and extract identity require confirmation, and isolated forskolin is a separate exposure. with Clonidine, RxCUI 2599, IN. The inspected oral immediate-release clonidine hydrochloride label explicitly identifies its clonidine free-base equivalent. That salt-to-active-ingredient bridge is restricted to the labeled oral formulation; patch, epidural and extended-release regimens are not assigned the same exposure automatically.
- Medication form and route
- oral
What remains uncertain
- Historical botanical naming and extract variability add uncertainty; studies do not include a clonidine comparison.
Factors that may matter: exact product and dose; baseline blood pressure; other medicines.
Read the supporting source summaries
Source 1: original clinical research
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 30 overweight or obese completers, 15 in each treatment group.
Table 2 showed no significant treatment-by-time difference in systolic or diastolic pressure.
How this applies: Neutral controlled evidence limits a blanket prediction of altered clonidine effectiveness.
Not a clonidine coadministration trial. Product and diet-specific results do not apply to every root or isolated forskolin preparation.
Source 2: original clinical research
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 49 patients enrolled; 41 completed two months of root preparations.
Both groups had lower pressure than at baseline; between-group differences were not significant.
How this applies: Keeps the positive uncontrolled signal distinct from direct interaction evidence.
Unblinded active-formulation comparison does not isolate a causal effect, and clonidine combination outcomes were not reported.
Source 3: botanical identity reference
mpns.science.kew.org · Source check Sep 10, 2026
Population: Botanical nomenclature, not a patient study.
Documents the medicinal naming connection and root use in pharmacopoeial sources.
How this applies: Allows related medicinal literature to be discussed with explicit identity and preparation limits.
A naming reference cannot verify a commercial product or make differing extracts equivalent. Historical scientific use of forskohlii is inconsistent.
Source 4: regulatory product labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral immediate-release clonidine.
Describes blood-pressure lowering, sedation, interactions with other sedating drugs, and potentially severe rebound hypertension after abrupt withdrawal.
How this applies: Defines medication context and prevents an unsupported recommendation to stop clonidine.
Does not directly test the botanical combinations in this batch. The free-base bridge is explicit in Description.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original article drafted after source checks. Exact preparation, route, contrary evidence and claim limitations recorded for review. | |
| Research summary published |
Article revision: 3816a29241c0fe9c
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.